Role of 4-1bb receptor in the control played by CD8+ T cells on IFN-γ production by Mycobacterium tuberculosis antigen-specific CD4+ T cells

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Palma, Carla ^a   Vendetti, Silvia ^a   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; DNA; GAMMA INTERFERON; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYCOBACTERIUM ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; BACTERIAL ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; IMMUNIZATION; IMMUNOSTIMULATION; IN VIVO STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; IMMUNOLOGY; PHYSIOLOGY; SPLEEN;

MUS; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD137; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; INTERFERON-GAMMA; MICE; MYCOBACTERIUM TUBERCULOSIS; SPLEEN;

EID: 77956194467     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011019     Document Type: Article

References (63)

1. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB 2008.393. Geneva: WHO, 2008.
2. Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC (2009) Tuberculosis vaccine research: the impact of immunology. Curr Opin Immunol 21: 331-338.
3. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon-c gene-disrupted mice. J Exp Med 178: 2243-2249.
4. Jung YJ, Ryan L, LaCourse R, North RJ (2005) Properties and protective value of the secondary versus primary T helper type 1 response to airbone Mycobacterium tuberculosis infection in mice. J Exp Med 201: 1915-1924.
5. Dannenberg AM, Jr., Collins FM (2001) Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis 81: 229-242.
6. Gonzales-Juarrero M, Turner J, Basaraba RJ, Belisle JT, Orme IM (2002) Florid pulmonary inflammatory responses in mice vaccinated with antigen-85 pulsed dendritic cells and challenged by aereosol with Mycobacterium tuberculosis. Cell Immunol 220: 13-19.
7. Ehlers S, Benini J, Held HD, Roeck C, Alber G, et al. (2001) abT cell receptor positive cells and IFN-γ, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J Exp Med 194: 1847-1859.
8. Elias D, Aruffo H, Britton S (2005) PPD induced in vitro IFN-γ production is not a reliable correlate of protection against Mycobacterium tuberculosis. Tran R Soc Trop Med Hyg 99: 363-368.
9. Leal IS, Smedegard B, Andersen P, Appelberg R (2001) Failure to induce enhanced protection against tuberculosis by increasing T cell-dependent interferon-c. Immunol 104: 157-161.
10. Palma C, Iona E, Giannoni F, Pardini M, Brunori L, et al. (2007) The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non protective Th1 immune response in mice. Cell Microbiol 9: 1455-1456.
11. Dietrich J, Andersen C, Rappuoli R, Doherty TM, Jensen CG, et al. (2006) Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boots prior bacillus Calmette-Guerin immunity. J Immunol 177: 6353-6360.
12. Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D'Souza S, et al. (2004) Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis 190: 2146-2153.
13. Hoft DF, Blazevic A, Abate G, Hanekom WA, Kaplan G, et al. (2008) A new recombinant bacilli Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 198: 1491-501.
14. Boesen H, Jensen BN, Wilcke T, Andersen P (1995) Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 63: 1491-1497.
15. Schwander SK, Torres M, Sada E, Carranza C, Ramos E, et al. (1998) Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis 178: 1434-1445.
16. Mittrücker HW, Steinhoff U, Köhler A, Krause M, Lazar D, et al. (2007) Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci USA 104: 12434-12439.
17. Koch R (1890) Weitere mittheilungen uber ein heilmittel gegen tuberkulose. Dtsch Med Wochenschr 16: 1029-1032.
18. + + CD25 T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis. Eur J Immunol 38: 695-705.
19. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, et al. (2000) IL-10- producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105: 1317-1325.
20. Delgado JC, Tsai EY, Thim S, Baena A, Boussiotis VA, et al. (2002) Antigenspecific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci USA 99: 7576-7581.
21. + T cells from TB patients. Tuberculosis 87: 526-534.
22. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
23. + + CD25 + FoxP3 + regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123: 50-59.
24. + + regulatory T cell subset that mediates suppression through the chemokine ligand 4. Proc Natl Acad Sci USA 104: 8029-8034.
25. Kwon BS, Weissman SM (1989) cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci USA 86: 1963-1967.
26. Pollok KE, Kim YJ, Zhou Z, Hurtado J, Kim KK, et al. (1993) Inducible T cell antigen 4-1BB. Analysis of expression and function. J Immunol 150: 771-781.
27. Watts TH (2005) TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23-68.
28. + T cells with similar efficacy. J Immunol 167: 1313-1324.
29. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 186: 47-55.
30. Melero I, Shuford WW, Newby SA, Aruffo A, Ledbetter JA, et al. (1997) Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 3: 682-685.
31. Wilcox RA, Flies DB, Zhu G, Johnson AJ, Tamada K, et al. (2002) Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J Clin Invest 109: 651-659.
32. + + CD25 + FoxP3 T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol 179: 7295-7304.
33. Mittler RS, Bailey TS, Klussman K, Trailsmith MD, Hoffmann MK (1999) Anti-4-1BB monoclonal antibodies abrogate T-cell dependent humoral immune responses in vivo through the induction of helper T cell anergy. J Exp Med 190: 1535-1540.
34. Seo SK, Choi JH, Kim YH, Kang WJ, Park HY, et al. (2004) 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med 10: 1088-1094.
35. Melero I, Murillo O, Dubrot J, Hervas-Stubbs S, Perez-Gracia JL (2008) Multilayered action mechanisms of CD137 (4-1BB)-targeted immunotherapies. Trends Pharmacol Sci 29: 383-390.
36. Palma C, Iona E, Giannoni F, Pardini M, Brunori L, et al. 2008. The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-γ response. Vaccine 26: 4237-43.
37. Lund FE (2006) Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity. Mol Med 12: 328-333.
38. +-related glycoprotein, CD233 (LAG-3). Eur J Immunol 32: 2255-2263.
39. Huang CT, Workman CJ, Flies X, Pan D, Marson AL, et al. (2004) Role of LAG-3 in regulatory T cells. Immunity 21: 503-513.
40. + T lymphocytes. Eur J Immunol 24: 3216-3221.
41. + T cells: a population of T cells with immune regulatory activities in vitro. Eur J Immunol 28: 3435-3447.
42. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, et al. (2006) Interleukin-10-secreting type 1 regulatory cells in rodents and humans. Immunol Rev 212: 28-50.
43. + + CD25 + regulatory T cells and immune tolerance. Autoimmunity 39: 269-276.
44. + T cells and participates in granuloma stability. J Leukoc Biol 82: 1221-1229.
45. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
46. Werninghaus K, Babiak A, Gross O, Hölscher C, Dietrich H, et al. (2009) Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRc-Syk-Card9-dependent innate immune activation. J Exp Med 206: 89-97.
47. Choi BK, Asai T, Vinay DS, Kim YH, Kwon BS (2006) 4-1BB-mediated amelioration of experimental uveoretinitis is caused by indoleamine 2,3 dioxygenase-dependent mechanisms. Cytokine 34: 233-242.
48. Stenger S, Mazzaccarro RJ, Uyemura K, Cho S, Barnes PF, et al. (1997) Differential effects of cytolytic T cell subsets on intracellular infection. Science 276: 1684-1687.
49. Olofsson PS, Sodersrom LA, Wagsater D, Sheikine Y, Ocaya P, et al. (2008) CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Cirulation 117: 1292-1301.
50. Giscombe R, Wang XB, Kakoulidou M, Lefvert AK (2006) Characterization of the expanded T-cell population in patients with Wegener's granulomatosis. J Intern Med 260: 224-230.
51. Mills KHG (2004) Regulatory cells: friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855.
52. Belkaid Y, Rouse BT (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6: 353-360.
53. + Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J Immunol 168: 3493-3501.
54. + T cell population in chronic hepatitis C virus infection. J Clin Invest 113: 963-972.
55. + T cells. J Immunol 168: 2247-2254.
56. + T cells. J Neuroimmunol 106: 43-52.
57. Ormer FM, de Souza JB, Riley EM 2003. Differential induction of TGF-b regulates proinflammatory cytokine production and determined the outcome of lethal and nonlethal Plasmodium yoelii infections. J Immunol 171: 5430-5436.
58. Kim YH, Choi BK, Kang WJ, Kim KH, Kang SW, et al. (2009) IFN-γindoleamine- 2,3 dioxygenase acts as a major suppressive factor in 4-1BBmediated immune suppression in vivo. J Leukoc Biol 85: 817-825.
59. Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, et al. (2004) Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 5: 46-57.
60. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, et al. (1995) Tumor necrosis factor-a is required in the protective immune response against Mycobacterium tuberculosis infection in mice. Immunity 2: 561-572.
61. Bean AG, Roach DR, Briscoe H, France MP, Korner H, et al. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aereosol Mycobacterium tuberculosis infection, which is not compensated for by lymphoyoxin. J Immunol 162: 3504-11.
62. Aagard C, Thanh Hoang TTK, Izzo A, Billeskov R, Troudt JL, et al. (2009) Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose. PloS ONE 4: e5930.
63. Boussaud V, Soler P, Moreau J, Goodwin RG, Hance AJ (1998) Expression of three members of the TNF-R family of receptors (4-1BB, Lymphotoxin-beta receptor and Fas) in human lung. Eur Respir J 12: 926-931.